Microphysiological systems—miniaturized models of human organs—are invaluable tools in biomedical research, enabling scientists to replicate the complex function of tissues and organs in vitro. However, a persistent challenge has been the precise modulation of interfacial properties between different tissue compartments, which critically influences cellular behavior and overall system function. Addressing this, the innovative use of pillar arrays as dynamic interfacial barriers offers a sophisticated means to manipulate mass transport, mechanical cues, and cellular interactions with heightened resolution.

The core concept revolves around deployable arrays of microfabricated pillars integrated within microfluidic chambers. These pillars serve as physical barriers whose properties—such as spacing, height, and stiffness—can be finely tuned to control permeability and mechanical interactions at the interfaces between distinct biological compartments. Unlike conventional static membranes, these arrays enable active modulation of signaling gradients and cellular crosstalk, closely mimicking physiological conditions.

One of the most striking aspects of this approach is the ability to customize the barrier properties according to experimental demands. By adjusting geometric parameters, researchers can regulate the degree of molecular diffusion or fluid flow between compartments, achieving tailored microenvironments that promote specific cellular phenotypes or responses. This flexibility is particularly crucial for mimicking complex organ interfaces such as the blood-brain barrier or alveolar-capillary junctions.

In practical implementation, the research team utilized advanced microfabrication techniques to assemble pillars composed of biocompatible polymer materials. These materials afford mechanical robustness coupled with customizable elastic properties, enabling the pillars to accommodate dynamic physiological stresses. Furthermore, surface functionalization protocols were employed to optimize cell adhesion and minimize nonspecific binding, ensuring faithful recreation of tissue interfaces.

Testing within liver- and lung-on-chip prototypes illustrated the profound effects of pillar array parameters on tissue function. Controlled modulation of mass transport altered hepatocyte metabolism and inflammatory responses, while precisely tuned barriers in lung models influenced epithelial cell integrity and barrier function, highlighting the system’s versatility across organ types. Such findings underscore the potential to mirror subtle physiological or pathological states by simply modifying interface characteristics.

From an engineering standpoint, the scalability and integrability of this pillar array platform stand out. It is compatible with high-throughput fabrication methods and can be seamlessly integrated into existing MPS devices, preserving microfluidic flow dynamics and optical accessibility for live imaging. This compatibility positions the technology for widespread adoption in pharmaceutical screening pipelines, where reproducibility and throughput are paramount.

Another compelling feature is the platform’s capacity to simulate the dynamic nature of biological interfaces. Where traditional barriers are fixed, the tunable pillar arrays allow real-time adjustment of interfacial resistance, opening new vistas for studying transient phenomena such as inflammation, barrier rupture, or drug transport kinetics under physiologically relevant conditions. This dynamic control capability could significantly advance our understanding of disease mechanisms.

The implications transcend academic research, carrying considerable promise for translational medicine. Enhanced microphysiological models built with these tunable barriers may improve predictions of human responses to new drugs, reducing reliance on animal testing and accelerating clinical development. Moreover, patient-specific MPS devices incorporating customized pillar arrays could yield personalized insights into disease progression and therapeutic efficacy.

As the frontier of bioengineering moves toward increasingly complex and accurate organ systems on chips, the granular control afforded by pillar arrays represents a paradigm shift. This technology complements advances in stem cell biology and sensor integration, collectively driving the creation of next-generation biomimetic platforms that can model human physiology with unrivaled fidelity.

Looking ahead, future research aims to expand the variety of pillar materials and configurations to capture a broader spectrum of organ-specific microenvironments. Additionally, integrating sensors directly within the pillar structures to monitor local biochemical and mechanical cues in situ is envisioned, providing comprehensive datasets that inform system optimization and application.

In summary, the development of tunable interfacial barriers through pillar arrays marks a significant milestone in microphysiological systems engineering. By offering a versatile, adjustable, and integrative platform, this technology enhances our ability to replicate complex tissue interfaces, ultimately enriching biomedical research and accelerating the path to precision therapeutics.

Subject of Research: Microphysiological systems and tunable interfacial barriers using pillar arrays.

Article Title: Pillar arrays as tunable interfacial barriers for microphysiological systems.

Article References:
Goswami, I., Kim, Y., Neiman, G. et al. Pillar arrays as tunable interfacial barriers for microphysiological systems. Commun Eng 4, 197 (2025). https://doi.org/10.1038/s44172-025-00527-x

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s44172-025-00527-x

To efficiently select an RS that faithfully encodes for a specific ncAA, researchers begin with the preparation of a mutant library sourced from the Methanomethylophilus alvus pyrrolysyl-RS. This library, which boasts a staggering 3.2 million members, serves as the key resource for identifying functional synthetases. By expertly engineering a variety of mutations within the RS, the potential for discovering a synthetase that correctly recognizes the target ncAA—and not canonical amino acids—is significantly enhanced. This vast array of candidates provides a unique opportunity for researchers to sift through potential variants until they find those that can effectively and reliably perform the desired function.

The subsequent phase of the procedure is a strategic selection process involving life and death selections, which plays a pivotal role in identifying functional RSs. During this phase, functional RSs that incorporate the ncAA into polypeptides will promote cell survival, while those that mistakenly incorporate canonical amino acids will lead to cellular death. This dichotomy allows for a streamlined approach to isolate the most effective RSs, thus enhancing the probability of success in future applications. The ability to create a selective environment in which only desired mutations can thrive is fundamental for achieving the desired outcomes in protein synthesis.

Following the initial selections, researchers implement fluorescence-based status checks. These checks provide vital metrics regarding the efficiency and fidelity of the surviving RSs in their ability to incorporate the target ncAA. The use of fluorescence as a readout is particularly advantageous, as it offers a real-time insight into the activity levels of the synthetases being tested. By quantifying the fluorescence emitted by cells expressing the engineered RSs, the researchers can assess their performance and make informed decisions about which candidates to further validate.

Characterizing the highest-performing RS/tRNA pairs is a crucial step in ensuring their usefulness for various applications. Once the top candidates have been selected, extensive characterization studies shed light on their functional capabilities in diverse biological contexts. These evaluations include assessing the stability of the RSs, their ability to work in cell-free protein expression systems, and their compatibility with both bacterial and eukaryotic host cells. Understanding these properties not only facilitates their practical application but also opens the door to exploring the biophysical characteristics of the engineered proteins.

Moreover, the stability of the Methanomethylophilus alvus RSs allows researchers to utilize them in a wide array of contexts. Their robustness can be leveraged in cell-free expression systems, whereby synthetic pathways can be realized without the limitations imposed by living cells. These systems present an exciting avenue for synthesizing proteins that may otherwise be too complex or deleterious to express in traditional cellular environments. Through cell-free expression, researchers can probe the functional attributes of newly synthesized proteins, exploring their potential uses in therapeutic and industrial applications.

Another notable aspect of this research is the improved efficiency it brings to the genetic encoding of noncanonical amino acids. Traditional methods of incorporating ncAAs often suffer from limitations in specificity and effectiveness, often resulting in low yield and undesirable byproducts. By establishing a reliable protocol for selecting optimized RS/tRNA pairs, this innovative approach has the potential to streamline the process of ncAA incorporation, thus accelerating the pace at which novel proteins can be engineered and developed.

The implications of this research extend well beyond academic realms. Industries ranging from pharmaceuticals to biotechnology stand to benefit profoundly from the enhanced capabilities that come with the reliable incorporation of ncAAs into proteins. For example, the ability to create proteins with unique properties can lead to the development of novel drugs with improved efficacy and reduced side effects. Additionally, these proteins can serve as building blocks for creating innovative biomaterials, with applications in fields such as tissue engineering and regenerative medicine, where customizability is key.

Furthermore, the findings of this study may also provide insights into the evolution of the genetic code itself. By demonstrating the feasibility of expanding the genetic repertoire through the incorporation of alternative amino acids, researchers can gain a deeper understanding of molecular evolution and the biochemical mechanisms that underpin life. The evolutionary implications of engineering the genetic code touch upon fundamental questions about genetic redundancy and the possibilities of alternative biochemistries.

As scientists continue to explore and refine the techniques outlined in this protocol, the anticipated timeline for selecting ncAA-specific RS/tRNA pairs ranges from approximately 30 to 50 days. This relatively short timeframe—given the complexity of the task—highlights the efficiency of the proposed method. The rigorous nature of the protocol, coupled with its reliance on status checks and characterization, ensures that researchers are equipped with all the tools necessary to make astute decisions about their candidates.

Given the rapid advancements in this field, continuous dialogue among researchers is critical. Collaboration and knowledge-sharing stand to accelerate the development of synthetic biology as a frontier of scientific inquiry. While the research has made significant strides, ongoing exploration will undoubtedly yield even more sophisticated methodologies and applications for ncAA integration. Scientists across multiple disciplines are enthusiastic about the potential impacts of this research, envisioning a landscape where the boundaries of biology are expanded further than ever thought possible.

Overall, the selection of ncAA-specific RS/tRNA pairs from a vast mutant library exemplifies a leap forward in genetic engineering techniques. The protocol promises to not only optimize the incorporation of noncanonical amino acids into proteins but also to advance our understanding of the nuances of protein synthesis and function. As researchers strive to unlock the full potential of synthetic biology, the findings within this study may lay the groundwork for a new generation of proteins equipped with unparalleled functionalities and characteristics.

In conclusion, the advancements surrounding the selection of aminoacyl-tRNA synthetases for noncanonical amino acid incorporation highlight the intersection of innovation and application in modern biology. As the field evolves, the tools and techniques developed will undoubtedly open new doors for exploration, offering scientists the opportunity to redefine the parameters of life itself.

Subject of Research: Engineering Aminoacyl-tRNA Synthetases for Noncanonical Amino Acid Incorporation

Article Title: Selecting aminoacyl-tRNA synthetase/tRNA pairs for efficient genetic encoding of noncanonical amino acids into proteins.

Article References:

Alexander, N.D., Gangarde, Y.M., Bednar, R.M. et al. Selecting aminoacyl-tRNA synthetase/tRNA pairs for efficient genetic encoding of noncanonical amino acids into proteins. Nat Protoc (2025). https://doi.org/10.1038/s41596-025-01241-w

Image Credits: AI Generated

DOI:

Keywords: Noncanonical amino acids, aminoacyl-tRNA synthetase, Methanomethylophilus alvus, genetic engineering, protein synthesis, synthetic biology

Tyrosine, a relatively underexploited amino acid residue compared to cysteine and lysine, presents a compelling chemical target owing to its unique phenolic side chain. However, its modification has traditionally suffered from poor selectivity and harsh reaction conditions that compromise protein integrity and function. Existing methods typically rely on electrophilic or radical chemistry that lack specificity, leading to heterogeneous products and undesired cross-reactivity. The newly reported selenoxide-based approach circumvents these limitations by utilizing a uniquely balanced reactivity profile, which operates efficiently in aqueous media without sacrificing precision.

Central to this innovative method is the exploitation of the well-known yet underutilized properties of selenium chemistry. Selenoxides, the oxidized forms of organoselenium compounds, exhibit distinct reactivity patterns that distinguish them from classical sulfur or oxygen analogs. Researchers have harnessed this to create a reagent capable of selectively engaging the phenolic hydroxyl group of tyrosine residues through chalcogen bonding—a non-covalent interaction involving selenium that rivals hydrogen bonds in strength and directionality. This interaction synergistically enhances the specificity and stability of the covalent attachment.

One of the pivotal insights of the study lies in the discovery that the selenoxide reagent operates via a mechanism combining directional chalcogen bonding with conventional hydrogen bonding, which collectively stabilizes the transition state leading to the modified protein. Remarkably, this dual interaction system exhibits substantial resistance to hydrolysis and other water-induced side reactions that have plagued previous tyrosine modification strategies. As a result, the reaction proceeds cleanly in fully aqueous buffer systems at physiological pH, maintaining native protein structures throughout the process.

Proteins subjected to this modification protocol retained their functional and structural integrity, as demonstrated by comprehensive biochemical assays and high-resolution spectroscopic analyses. The researchers meticulously verified that the single-atom insertion at the tyrosine side chain did not perturb folding motifs or catalytic activity, an essential criterion for downstream biomedical applications. This degree of biocompatibility is unprecedented for tyrosine-targeted chemistries and suggests vast potential for site-specific labeling or therapeutic conjugation.

The chemical selectivity achieved by this selenoxide-mediated reaction stands out, especially in complex biological milieus where competing nucleophiles and reductants abound. The reagent exhibits minimal cross-reactivity with other amino acid residues, including cysteine, lysine, and histidine, which often complicate selective modification. This precision stems from the tailored electronic properties of the selenoxide moiety and its unique ability to form directional chalcogen bonds, a concept recently gaining momentum across supramolecular and medicinal chemistry.

Looking ahead, this work not only pioneers a novel chemical toolkit for protein functionalization but also expands our fundamental understanding of noncovalent interactions involving chalcogen elements in biological systems. The interplay between selenium’s electronic characteristics and hydrogen bonding offers new strategies to fine-tune reactivity and selectivity, potentially inspiring the design of next-generation bioconjugation agents, chemical probes, and enzyme inhibitors.

Importantly, the water resistance of this selenoxide-based chemistry addresses a critical bottleneck in in vivo applications. Many existing labeling reactions falter under physiological conditions due to hydrolytic degradation or competing nucleophiles present in cells and tissues. The robustness of this method in aqueous environments hints at future possibilities for live-cell labeling, site-specific drug delivery, and real-time monitoring of post-translational modifications with minimal off-target effects or cytotoxicity.

Furthermore, the molecular precision afforded by single-atom modifications offers exciting prospects for synthetic biology, where tailored mutations or chemical attachments can endow proteins with novel functionalities. The ability to selectively modify tyrosines without disrupting other residues provides a powerful handle to engineer enzyme active sites, modulate signaling pathways, or create hybrid protein-material constructs with unprecedented control.

This research also underscores the potential for selenium chemistry’s broader integration into biological contexts. Historically overshadowed by sulfur and oxygen analogs, selenium’s unique properties are now being appreciated as an enabling platform for sophisticated molecular engineering. The present work exemplifies how careful design and mechanistic understanding can unlock selenium’s potential in a biologically compatible fashion.

From a technological standpoint, the scalability and operational simplicity of the selenoxide reagent synthesis further bolster its appeal. Unlike more complicated or unstable bioconjugation reagents, the selenoxide compound can be prepared in high yield and is stable under storage, facilitating widespread adoption by laboratories focused on protein science, chemical biology, and pharmaceutical development.

The conceptual leap made here may also influence the design of other chalcogen-based reagents aimed at modifying different amino acid residues or protein motifs. By expanding the chalcogen bonding paradigm, chemists may discover new ways to harness subtle electronic interactions for high-fidelity molecular recognition and catalysis in biological environments.

This achievement is poised to impact multiple sectors, including therapeutic antibody conjugation, where precise modification of tyrosine residues can improve drug-to-antibody ratios and pharmacokinetic profiles. It also holds promise for the development of protein-based sensors or imaging agents that require site-specific attachment of fluorescent dyes or radioisotopes without compromising biomolecular structure.

In essence, the ability to install a single atom selectively onto tyrosine’s phenol group using this novel selenoxide chemistry stands as a testament to the power of combining fundamental inorganic chemistry insights with cutting-edge protein science. This breakthrough sets a new gold standard for precision protein modification in aqueous media, a feat once thought to be extraordinarily challenging.

The implications extend beyond merely creating a new chemical reaction; they reshape how scientists conceive enzyme engineering, post-translational modification mimics, and the broader interface between synthetic chemistry and biology. By enabling rapid, selective, and stable labeling in water, this method aligns perfectly with the growing demand for biocompatible and minimally invasive molecular tools.

Overall, the introduction of this water-resistant chalcogen and hydrogen bonding-enabled selenoxide reagent heralds a new era in protein modification technology. Its unique combination of selectivity, stability, ease of use, and compatibility with physiological conditions will likely stimulate a wave of innovation across chemical biology, therapeutic development, and synthetic protein design. As the scientific community continues to explore and expand these concepts, we can expect to see significant advances in both fundamental understanding and practical applications, dramatically enhancing our ability to manipulate and harness protein function at the atomic level.

Subject of Research: Single-atom protein modification of tyrosine residues using selenoxide-based chemistry enabled by water-resistant chalcogen and hydrogen bonding interactions.

Article Title: A selenoxide for single-atom protein modification of tyrosine residues enabled by water-resistant chalcogen and hydrogen bonding.

Article References:

Lin, S., Hirao, M., Hartmann, P. et al. A selenoxide for single-atom protein modification of tyrosine residues enabled by water-resistant chalcogen and hydrogen bonding.
Nat. Chem. (2025). https://doi.org/10.1038/s41557-025-01842-8

Image Credits: AI Generated